End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.34 USD | +19.15% | +56.81% | -43.39% |
Business Summary
Number of employees: 1,525
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Patient Service
98.9
%
| 1,138 | 99.0 % | 1,266 | 98.9 % | +11.23% |
Other
1.1
%
| 12 | 1.0 % | 13 | 1.1 % | +14.72% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1,150 | 100.0 % | 1,279 | 100.0 % | +11.27% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Todd Schonherz
CEO | Chief Executive Officer | 54 | 23-09-19 |
David Afshar
DFI | Director of Finance/CFO | 52 | 05-16 |
Stephen Divers
CTO | Chief Tech/Sci/R&D Officer | 51 | 23-09-19 |
Erica Mallon
LAW | General Counsel | - | 23-09-19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bradley Fluegel
BRD | Director/Board Member | 62 | 23-09-19 |
James Stith
BRD | Director/Board Member | 40 | 23-09-19 |
Todd Schonherz
CEO | Chief Executive Officer | 54 | 23-09-19 |
Ravi Sarin
BRD | Director/Board Member | 42 | 23-09-19 |
Stephen Divers
CTO | Chief Tech/Sci/R&D Officer | 51 | 23-09-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 23,725,998 | 0 | 0 | 58.29 % |
Stock B | 1 | 13,077,512 | 7,623,286 ( 58.29 %) | 31,170 ( 0.2383 %) | |
Stock C | 0 | 6,651,610 | 0 | 0 |
Company contact information
American Oncology Network, Inc.
14543 Global Parkway Suite 110
33913, Fort Myers
+
http://www.aoncology.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-43.39% | 24.7M | |
+22.99% | 87.14B | |
-23.70% | 75.59B | |
+1.76% | 26.78B | |
+3.99% | 17.89B | |
-14.08% | 16.44B | |
+2.79% | 15.68B | |
+69.20% | 13.3B | |
+76.10% | 13.06B | |
+3.11% | 12.54B |
- Stock Market
- Equities
- AONC Stock
- Company American Oncology Network, Inc.